These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

156 related articles for article (PubMed ID: 38105408)

  • 1. Deciphering the Biophysical Properties of Ion Channel Gating Pores by Coumarin-Benzodiazepine Hybrid Derivatives: Selective AMPA Receptor Antagonists.
    Qneibi M; Hawash M; Gümüş M; Çapan İ; Sert Y; Bdir S; Koca İ; Bdair M
    Mol Neurobiol; 2024 Jul; 61(7):4565-4576. PubMed ID: 38105408
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Affecting AMPA Receptor Biophysical Gating Properties with Negative Allosteric Modulators.
    Qneibi M; Hawash M; Jaradat N; Bdir S
    Mol Neurobiol; 2022 Sep; 59(9):5264-5275. PubMed ID: 35687302
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Electrophysiological Assessment of Newly Synthesized 2,3-Benzodiazepine Derivatives for Inhibiting the AMPA Receptor Channel.
    Qneibi M; Jumaa H; Bdir S; Al-Maharik N
    Molecules; 2023 Aug; 28(16):. PubMed ID: 37630319
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Inhibition and assessment of the biophysical gating properties of GluA2 and GluA2/A3 AMPA receptors using curcumin derivatives.
    Qneibi M; Hamed O; Natsheh AR; Fares O; Jaradat N; Emwas N; AbuHasan Q; Al-Kerm R; Al-Kerm R
    PLoS One; 2019; 14(8):e0221132. PubMed ID: 31454362
    [TBL] [Abstract][Full Text] [Related]  

  • 5. α-Lipoic Acid Derivatives as Allosteric Modulators for Targeting AMPA-Type Glutamate Receptors' Gating Modules.
    Qneibi M; Nassar S; Bdir S; Hidmi A
    Cells; 2022 Nov; 11(22):. PubMed ID: 36429036
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The AMPA receptor biophysical gating properties and binding site: Focus on novel curcumin-based diazepines as non-competitive antagonists.
    Qneibi M; Hamed O; Jaradat N; Hawash M; Al-Kerm R; Al-Kerm R; Sobuh S; Tarazi S
    Bioorg Chem; 2021 Nov; 116():105406. PubMed ID: 34628227
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Allosteric regulation of alpha-amino-3-hydroxy-5-methyl-4-isoxazole-propionate receptors by thiocyanate and cyclothiazide at a common modulatory site distinct from that of 2,3-benzodiazepines.
    Donevan SD; Rogawski MA
    Neuroscience; 1998 Dec; 87(3):615-29. PubMed ID: 9758228
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The inhibitory role of curcumin derivatives on AMPA receptor subunits and their effect on the gating biophysical properties.
    Qneibi M; Hamed O; Fares O; Jaradat N; Natsheh AR; AbuHasan Q; Emwas N; Al-Kerm R; Al-Kerm R
    Eur J Pharm Sci; 2019 Aug; 136():104951. PubMed ID: 31173869
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pharmacology of AMPA/kainate receptor ligands and their therapeutic potential in neurological and psychiatric disorders.
    Lees GJ
    Drugs; 2000 Jan; 59(1):33-78. PubMed ID: 10718099
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Influence of the TARP γ8-Selective Negative Allosteric Modulator JNJ-55511118 on AMPA Receptor Gating and Channel Conductance.
    Coombs ID; Sexton CA; Cull-Candy SG; Farrant M
    Mol Pharmacol; 2022 May; 101(5):343-356. PubMed ID: 35246481
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The new 2,3-benzodiazepine derivative EGIS-8332 inhibits AMPA/kainate ion channels and cell death.
    Vegh MG; Kovács AD; Kovács G; Szabó G; Tihanyi K; Hársing LG; Lévay G
    Neurochem Int; 2007 Feb; 50(3):555-63. PubMed ID: 17147974
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Positive modulation of alpha-amino-3-hydroxy-5-methyl-4-isoxazole propionic acid (AMPA) receptors in prefrontal cortical pyramidal neurons by a novel allosteric potentiator.
    Baumbarger PJ; Muhlhauser M; Zhai J; Yang CR; Nisenbaum ES
    J Pharmacol Exp Ther; 2001 Jul; 298(1):86-102. PubMed ID: 11408529
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Presynaptic alpha-amino-3-hydroxy-5-methyl-4-isoxazole propionate receptor-mediated stimulation of glutamate and GABA release in the rat striatum in vivo: a dual-label microdialysis study.
    Patel DR; Young AM; Croucher MJ
    Neuroscience; 2001; 102(1):101-11. PubMed ID: 11226673
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Negative allosteric modulation of AMPA-preferring receptors by the selective isomer GYKI 53784 (LY303070), a specific non-competitive AMPA antagonist.
    Ruel J; Guitton MJ; Puell JL
    CNS Drug Rev; 2002; 8(3):235-54. PubMed ID: 12353057
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Mechanism of inhibition of the GluR2 AMPA receptor channel opening by 2,3-benzodiazepine derivatives.
    Ritz M; Micale N; Grasso S; Niu L
    Biochemistry; 2008 Jan; 47(3):1061-9. PubMed ID: 18161947
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Mechanism and site of inhibition of AMPA receptors: substitution of one and two methyl groups at the 4-aminophenyl ring of 2,3-benzodiazepine and implications in the "E" site.
    Wang C; Wu A; Shen YC; Ettari R; Grasso S; Niu L
    ACS Chem Neurosci; 2015 Aug; 6(8):1371-8. PubMed ID: 25967651
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Functional insight into development of positive allosteric modulators of AMPA receptors.
    Weeks AM; Harms JE; Partin KM; Benveniste M
    Neuropharmacology; 2014 Oct; 85():57-66. PubMed ID: 24878241
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cyclothiazide acts at a site on the alpha-amino-3-hydroxy-5-methyl-4-isoxazole propionic acid receptor complex that does not recognize competitive or noncompetitive AMPA receptor antagonists.
    Desai MA; Burnett JP; Ornstein PL; Schoepp DD
    J Pharmacol Exp Ther; 1995 Jan; 272(1):38-43. PubMed ID: 7529311
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Mutational Analysis and Modeling of Negative Allosteric Modulator Binding Sites in AMPA Receptors.
    Stenum-Berg C; Musgaard M; Chavez-Abiega S; Thisted CL; Barrella L; Biggin PC; Kristensen AS
    Mol Pharmacol; 2019 Dec; 96(6):835-850. PubMed ID: 31582576
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pharmacological characterization of cGMP regulation by the biarylpropylsulfonamide class of positive, allosteric modulators of alpha-amino-3-hydroxy-5-methyl-4-isoxazolepropionic acid receptors.
    Ryder JW; Falcone JF; Manro JR; Svensson KA; Merchant KM
    J Pharmacol Exp Ther; 2006 Oct; 319(1):293-8. PubMed ID: 16803862
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.